39°

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
- Local News
- State News
Sports
- Local Sports
- Pro Sports
Lifestyle
- Local Entertainment
Multimedia
Community Choice
Features
Classifieds
- Place Ad
- Legal Notices
Public Notices
Obituaries
E-Edition
STOCKING STUFFER CONTEST

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

VYNE Therapeutics Inc. - Common Stock (NQ:VYNE)

0.3746 -0.0001 (-0.03%)

Streaming Delayed Price Updated: 3:14 PM EST, Dec 4, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about VYNE Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Vyne Therapeutics Inc. (NASDAQ: VYNE) is One of Wednesday Morning’s Most Active Stocks

April 19, 2023

Via Investor Brand Network

Dow Drops Over 100 Points; Morgan Stanley Profit Beats Views ↗

April 19, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping over 100 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.34% to 33,860.62 while the NASDAQ fell...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 19, 2023

Via Benzinga

7 Sorry Pharma Stocks to Sell in April Before It’s Too Late ↗

April 16, 2023

You have to be patient when investing in pharma stocks. But sometimes the risk and the wait aren't worth the rewards.

Via InvestorPlace

VYNE Therapeutics Touts Encouraging Pharmacokinetic, Hematology Data From Potential Candidate For Skin Disorder ↗

March 30, 2023

Via Benzinga

Why Penny Stock VYNE Therapeutics Is Skyrocketing Today? ↗

January 10, 2023

Via Benzinga

VYNE Therapeutics: Q2 Earnings Insights ↗

August 12, 2022

VYNE Therapeutics (NASDAQ:VYNE) reported its Q2 earnings results on Friday, August 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why Agile Therapeutics Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket ↗

March 23, 2023

Gainers ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) shares rose 82.8% to $2.98 in pre-market trading. ZyVersa Therapeutics recently reported new employment inducement grants under Nasdaq Listing Rule...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

March 23, 2023

We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Thursday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 08, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 13, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 11, 2023

Via Benzinga

Dow Rises Over 100 Points; Rayonier Advanced Materials Shares Plunge ↗

January 10, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 100 points on Tuesday. The Dow traded up 0.40% to 33,653.27 while the NASDAQ rose 0.83% to 10,724.37. The S&P...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 10, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 10, 2023

Via Benzinga

Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 10, 2023

Gainers

Via Benzinga

Why VYNE Therapeutics Shares Are Trading Higher By 82%; Here Are 20 Stocks Moving Premarket ↗

January 10, 2023

Gainers VYNE Therapeutics Inc. (NASDAQ: VYNE) rose 82.2% to $0.35 in pre-market trading after the company said first vitiligo patient was dosed in Phase 1a/b clinical trial of novel BET inhibitor...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

January 10, 2023

We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about for Tuesday!

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 09, 2023

Via Benzinga

Why CinCor Pharma Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket ↗

January 09, 2023

Gainers CinCor Pharma, Inc. (NASDAQ: CINC) rose 140.2% to $28.30 in pre-market trading after AstraZeneca announced plans to buy the company for up to $1.8 billion.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

January 09, 2023

We're starting off the week with a look at the biggest pre-market stock movers traders need to know about on Monday morning!

Via InvestorPlace

Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 09, 2023

Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 06, 2023

Via Benzinga

Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 05, 2023

Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 05, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 04, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 04, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

September 22, 2022

On Thursday, 1076 companies hit new 52-week lows.

Via Benzinga

VYNE Therapeutics Earnings Perspective: Return On Capital Employed ↗

September 09, 2022

VYNE Therapeutics (NASDAQ:VYNE) brought in sales totaling $126 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 281.5%, resulting in a loss of $8.48 million.

Via Benzinga

Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday ↗

August 11, 2022

Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Multimedia
Local Events
Classifieds
Obituaries
Weather
Online Features

Services

About Us
Contact Us
Promote Your Event
Subscriber Services
Online Forms
Rack Locations

woonsocketcall.com
Address: 154 Main Street
Woonsocket, RI 02895
Phone: 401-762-3000
Email: notices@woonsocketcall.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

VYNE Therapeutics Inc. - Common Stock (NQ:VYNE)

All News about VYNE Therapeutics Inc. - Common Stock

Sections

Services